Literature DB >> 10206270

Making the most of rodent tumour systems in cancer drug discovery.

M C Bibby1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206270      PMCID: PMC2362798          DOI: 10.1038/sj.bjc.6690261

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  62 in total

Review 1.  Gene therapy strategies for tumor antiangiogenesis.

Authors:  H L Kong; R G Crystal
Journal:  J Natl Cancer Inst       Date:  1998-02-18       Impact factor: 13.506

2.  The effects of single dose oral hydralazine on blood flow through human lung tumours.

Authors:  N P Rowell; M A Flower; V R McCready; B Cronin; A Horwich
Journal:  Radiother Oncol       Date:  1990-08       Impact factor: 6.280

3.  Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo.

Authors:  G W Rewcastle; G J Atwell; B C Baguley; S B Calveley; W A Denny
Journal:  J Med Chem       Date:  1989-04       Impact factor: 7.446

Review 4.  Drug-polymer conjugates: potential for improved chemotherapy.

Authors:  R Duncan
Journal:  Anticancer Drugs       Date:  1992-06       Impact factor: 2.248

5.  Description of a murine model of experimental hepatic metastases.

Authors:  M H Goldrosen; N Paolini; E D Holyoke
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

Review 6.  Chemical modification of tumour blood flow.

Authors:  R L Jirtle
Journal:  Int J Hyperthermia       Date:  1988 Jul-Aug       Impact factor: 3.914

Review 7.  Therapeutic index: a vital component in selection of anticancer agents for clinical trial.

Authors:  J A Double; M C Bibby
Journal:  J Natl Cancer Inst       Date:  1989-07-05       Impact factor: 13.506

8.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

9.  The logistics of broader pre-clinical evaluation of potential anti-cancer agents with reference to anti-tumour activity and toxicity of mitozolomide.

Authors:  M C Bibby; J A Double; I A Wahed; N Hirbawi; T G Baker
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

Review 10.  Tumour vasculature--a potential therapeutic target.

Authors:  C T Baillie; M C Winslet; N J Bradley
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.